& about . National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)National Institutes of HealthPublic Health Service • U.S. Department of Health and Human Services For Your Information This publication contains information about medicationsused to treat the health condition discussed in this booklet.When this booklet was printed, we included the most up-to-date (accurate) information available. Occasionally,new information on medication is released.
Microsoft word - vol_01_15.docProceedings of the Third Annual Meeting for Animal Production Under Arid Conditions, Vol. 1: 150-159 1998 United Arab Emirates University. Efficacy of Closantel Plus Albendazole Liquid
Suspension against Natural Infection of
Gastrointestinal Parasites in Jordanian Camels
K.M. Al-Qudah, L.A. Sharif, O.F. Al-Rawashdeh and F.K. Al-Ani Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, P.O. Box 3030 Irbid, Jordan. ABSTRACT
Oral administration of closantel in a dose of 10 mg/kg plus albendazole in a dose of 5mg/kg liquid suspension was studied in 75 camels naturally infected with various types of gastrointestinal parasites. The camels involved were 15 pregnant she-camels, 20 non-pregnant she-camels and 40 male camels of various ages. Each camel received a single oral dose of closantel (10 mg/kg) plus albendazole (15 mg/kg) orally. Two weeks later, 20 camels of this group were re-dosed again with the same dose of the anthelmintic. Fecal samples were collected from the rectum of all the camels at the time of treatment and again 14 and 42 days post treatment. Fecal egg counts and generic determination of third stage larvae was performed. Results indicated that six different species of gastrointestinal tract parasites were identified in camels. A single treatment of closental plus albendazole mixture reduced egg counts in camels by 100%, 99%, 98% and 77% for H. longistipes, Ascaris spp., Monezia expansa and Fasciola hepatica, respectively. However, administration of the drug twice, two weeks apart, significantly
raised the efficacy of the drug for clearance of the parasites from
92.5% to 100% in camels affected with various parasites. Camels
were not adversely affected by treatment.
Key words: Closental, Albendazole, Parasites, Camels, Jordan.
The dromedary camel (Camelus dromedarius) is an important domestic animal in Jordan (FAO, 1995). The vast majority of the
camels are found in the Northern and Eastern regions of Jordan.
Several investigators reported the occurrence of different helminthes
in camels in different parts of the world (Altaif, 1974; Dakkak and
Ouhelli, 1987, El-Bihari et al., 1984 and Magzoub et al., 1997).
Mixed infection in which two or three parasites are present in the
same animal were diagnosed (Altaif, 1974; Selim and Rahman,
1972). Thus, a combination of anthelmintics to control the different
types of camel parasites was reported. Closantel, which is an
antiparasitic agent of broad-spectrum, is used against several species
and developmental stages of trematodes, nematodes and arthropods
in different animal host species. It has been used efficiently in
controlling haemonchosis in goats (Dorny et al., 1994), levamisole-
resistant Haemonchus contortus of sheep (Yadav and Kumar, 1994),
Oestrus ovis of sheep (Alzieu et al., 1994), Fasciola hepatica in
sheep and cattle (Boulard et al., 1995; Sanchez and Quiroz-Romero,
1995), bovine hypodermosis (Hennessy et al., 1993) and Ixodes
ricinus tick of sheep (Bates et al., 1995). As far as we are aware, no
report for the use of closantel and albendazole suspension against
various gastrointestinal parasites of camels was found in the
available literature. Therefore, the aim of the present study was
undertaken to evaluate the therapeutic efficacy of a mixture of
closantel and albendazole against various gastrointestinal parasites
of camels kept under field conditions in Jordan.
MATERIALS AND METHODS
A herd of 250 one-humped camels (Camelus dromedarius) was selected for this clinical trial. All were working animals, kept in the northern desert of Jordan where they were fed grass hay together with a supplementary grain ration. No anthelmintics were administered for at least 6 months preceding the trial. One hundred camels of both sexes and of different ages were selected at random to test the efficacy of a mixture of closantel and albendazole on different kinds of gastrointestinal parasites. The camels were divided into two groups. Group one involved 75 camels suffering from
different kinds of gastrointestinal parasites. They included 15
pregnant she-camels, 20 non-pregnant she-camels and 40 males of
different ages. All were treated on an individual body weight basis,
according to manufacturer's recommended dose rates. Each animal
received closantel (10 mg/kg) and albendazole (5 mg/kg) liquid
suspension orally. Moreover, 20 camels of this group (15 pregnant
she-camel and 5 males) were re-dosed with the same medication 2
weeks after the initial dose. Group two involved 25 camels of various
ages and sexes which, were naturally infected with different
gastrointestinal parasites, but remained untreated as controls. All
animals were subjected to daily clinical examination to find if there
was any side effect of the anthelmintics on the animals or their feti.
Fecal samples were collected from the rectum of all camels at the time of treatment and again 14 and 42 days post treatment. Direct method of examination including flotation and sedimentation methods were performed. Faecal egg counts were carried out by McMaster method (Thienpont et al., 1979). Faecal samples from each group at day 0, 14 and 42 days were cultured and generic determination was performed on third stage larvae reared in faecal culture. The efficacy of treatment was measured by fecal egg count reduction (FECR) test, according to the methods described by Dash, et al (1988). All animals were also subjected to daily clinical examination for any side effect of the anthelmintic on the animals and feti. The incidence of mixed helminthic infection was 53% while that of single infection was 47% (Table 1). Six different species of gastrointestinal worms were identified in Jordanian camels. They were classified according to the site of lodging in the gastrointestinal tract and liver. The abomasal worm was identified as Haemonchus longistipes, with prevalence rate of 8%. Three small intestinal worms were identified and their prevalence rates were Trychostrongylus probolurus (73.3%), Ascaris spp. (29.3%) and Monezia expansa (17.3%). Finally, two large intestinal and liver worms were identified. Trichuris ovis and Fasciola hepatica with prevalence rate of 20% and 5.5%, respectively. The intensity of infection for all identified parasites was medium to high. Parasitic eggs output before treatment ranged from 2,000 to 10,000 eggs per gram of feces.In the treatment group, clearance of parasites was significantly higher (P < 0.05) after 6 weeks of treatment than after 2 weeks of treatment (Table 1). The clearance rate of the parasites after 2 weeks of treatment ranged from 25% for Fasciola hepatica to 73.3% for Trichurus ovis with an average rate of 49.6% for all the identified parasites . However, the clearance rate of the parasites after 6 weeks of treatment ranged from 75% for Fasciola hepatica to 93.3% for Trichurus ovis with an average rate of 88.7% for all the identified parasites (Table 1). Table 1: Efficacy of closantel plus albendazole mixture in treating 75 Camels with different gastrointestinal parasites. Clearance time after Trychostrongylus 55 (73.3) 26 (47.3) 50 (90.9) (29.3) 9 (40.0) 17 (81.8) (17.3) 9 (69.2) 12 (92.3) (20.0) 11 (73.3) 14 (93.3) (5.5) 1 (25.0) 3 (75.0) (8.0) 1 (50.0) 5 (83.3) *115 = No. of parasites identified in 40 mixed infection plus 35 single infection The percentage reduction of the fecal egg counts is set out in Table 2. Single treatments of closantel plus albendazole mixture reduced egg counts by 100%, 100%, 98% and 77%, for H. longistipes, Ascaris spp., Monezia expansa and Fasciola hepatica, respectively. Administration of the drug twice, of two weeks apart, significantly raised (P < 0.05) the efficacy of the drug for clearance of the parasites from 92.5% to 100% in camels infected with single type of parasite, and from 75% to 100% in camels infected with mixed parasites (Table 2). On the other hand, the efficacy of the drug for clearance of the parasites was significantly higher (P < 0.05) in animals infected with a single parasite than in the animals infected with mixed types of parasites. No fatality, abortion or congenital anomalies were recorded in any animal receiving medication under the trial. The egg count in untreated camels were 2,500 egg / gram or more during the experiment. Table 2: Efficacy of single and double doses of closantel plus albendazole mixture in treating camels infected with gastrointestinal parasites. infection Mixed infection 8 (100) 12 12 (100) *10 mg/kg for closantel plus 5 mg/kg for albendazole. **Two doses 2 weeks apart.
In Jordan, the prevalence of gastrointestinal parasitic infection in camels was very high. Mixed infection in which two or even three parasites were present in the same animals were diagnosed. These findings were in agreement with the finding of (Selim and Rahman, 1972). Six species of helminths (4 nematodes, 1 cestode and 1 trematode) were found in camels examined in the present study. Haemonchus longistipes is the common abomasal nematodes which has been reported from almost all countries in which camels are kept (El-Bihari, 1985). Other helminths which are reported in camels include Ostertagia spp., Cooperia spp., Bunostomum spp., Nematodirella spp., Impalaia nudicollis and Impalai tuberculata have been reported from India, Kenya and Egypt (Soliman, 1956). Except for Camelostrongylus mentulatus, all the species found in our study were either parasites of sheep, cattle or horses. Closantel is a broad-spectrum antiparasitic agent used against several species and the developmental stage of trematodes, nematodes and anthropodes in different animal host species (Dorny et al., 1994; Yadav and Kumar, 1994; Barger et al., 1991; Guerrero, 1984; Gupta and Yadav, 1994; Hall et al., 1981 and Owen, 1988). Closantel has been used in a dose of 5 mg/kg body weight given by subcutaneous injection or a dose of 10 mg/kg body weight gives orally for the treatment of H. contortus in goats (Dorny et al., 1994). An oral dose of 7.5 mg/kg body weight given virtually complete protection against H. contortus for at least 4 weeks in sheep (Owen, 1988). Also, closantel prevented establishment of re-infections with H. contortus in sheep for at least 2 weeks with an oral dose of 10 mg/kg body weight and for 4-5 weeks with a dose of 10 mg/kg subcutaneously (Hennessy et al., 1993). There is some uncertainty about the development of resistance against closantel since selection of resistant worms may be enhanced if the sustained activity is associated with a prolonged period of decreasing drug concentration (Dash, 1986). There have been reports of closantel resistance in H. contortus in sheep in South Africa (Van Wyk and Malan, 1988; and Van Wyk et al., 1982) and Australia (Rolfe et al., 1990). Our results showed that mixed infection in camels is high. Therefore, in order to preserve the full potential of closantel and to control mixed infection, it is recommended that administration of the drug be used in full dose and in combination with other broad-spectrum anthelmintics. Albendazole is widely used as a broad-spectrum anthelmintic. At a doses of 7.5 mg/kg body weight used as a broad-spectrum anthelmintic, at a dose of 7.5% mg/kg body weight, albendazole has been reported to have good efficacy against mature F. hepatica in sheep (Campbell and Hall, 1979). There has been some concern about the safety of closantel in animals. Spongiform changes in the brain and retinal degeneration causing blindness have been associated with overdose of closantel in kid goats (Button et al., 1987) and adult goats and sheep (Obowlo et al., 1989). In dogs, a case of overdose with closantel was described. The dog received 6 times the recommended dosage of closantel. The main clinical signs were optic neuritis, retinal degeneration, partial deafness, hepatotoxicosis and myopathy (McEntee et al., 1995). The present study demonstrated the high efficacy of a mixture of closantel and albendazole against various gastrointestinal parasites
of camels. Also, we recommend giving the mixture into two doses.
The first dose reduced egg counts by 75 to 93.3% and the second
dose cleared most animals of all parasites. However, according to the
available literature, this is the first report on the use of closantel for
the treatment of gastrointestinal parasites in camels. Our results and
the follow up of the treated camels showed that a mixture of closantel
plus albendazole did not cause any adverse reaction in the 75 camels
treated in this study.
Altaif, K.I. 1974. Helminths in camels in Iraq. Tropical Animal
Health Production, 6: 55-57. Alzieu, J.P., P. Dorchies, F. Donat and O. Chiarisoli. 1994. New findings of the epidemiology of estrus ovis and its control by closantel. Point Veterinaire, 162: 363-369. Barger, I.A., E. Hall, K.M. and Dash. 1991. Local eradication of Haemonchus contortus using closantel. Australian Veterinary Journal, 68: 347-348. Bates, P.G., M.R. Rankin and D.J Bartram. 1995. Reduced fecundity and egg viability in the pasture tick Ixodes ricinus exposed to closantel. Veterinary Record. 137 17: 437-438. Boulard, C., F. Carreras and F.V. Gool. 1995. Evaluation of nitroxynil and closantel activity using ELISA and egg counts against Fasciola hepatica in experimentally and naturally infected cattle. Veterinary Research, 26 4: 249-255. Button, C., I. Jerrett, P. Alexander and W. Mizon. 1987. Blindness in kids associated with overdosage of closantel. Aust. Vet. J. 64: 226. Campbell, N.J. and C.A Hall. 1979. The anthelmintic efficacy of albendazole against Fasciola hepatica and benzimidazole resistant strains of Haemonchus contortus and Trichostrongylus colubriformis in sheep. Research in Veterinary Science. 26, 90-93. Dakkak, A. and H. Ouhelli. 1987. Helminths and helminthoses of the dromedary. A review of the literature. Rev. Sci. Tech. Off. Int. Epiz. 6, 447-461. Dash, K.M. 1986. Control of helmenthosis in lambs by strategic treatment with closantel and broad-spectrum antihelmintics. Aust. Vet. J. 63: 4-8. Dash, K.M., E. Hall and I.A. Barger. 1988. The role of arithmetic and geometric mean worm egg counts in faecal egg count reduction tests and in monitoring strategic drenching programs in sheep. Australian Veterinary Journal. 66-67. Dorny, P., J. Vercruysse, A. Jalila, R. Sani, and C. Symoens. 1994. Control of haemonchosis in Malaysian goats with closantel. Vet. Parasitol., 53: 233-241. El-Bihari, S. 1985. Helminths of the camel: a review. British Veterinary Journal. 141, 315-325. El-Bihari, S., Z.A. Kawasmeh, N.A. Ashour, and A.H. El-Naiem. 1984. Experimental infection of sheep by the camel stomch worm Haemonchus longistipes. Vet. Parasitology. 15: 257-262. FAO Production Yearbook. 1995. The Middle East and North Africa. 41 Edition. Europe Publications Limited, England, pp. 593. Guerrero, J. 1984. Closantel: A review of its antiparasitic activity. Prev. Vet. Med. 2: 317-327. Gupta, S.C. and S.C. Yadav. 1994. Efficacy of closantel against immature Fasciola gigantica infection in goat. J. Vet. Parasitol., 8: 51-52. Hall, C.A., J.D. Kelly, H.V. Whitlock, and K. Ritchie. 1981. Prolonged antihelmintic effect of closantel and disophenol against a thiabendazol selected against resistant strain of Haemonchus contortus on sheep. Res. Vet. Sci., 31: 104-106. Hennessy, D.R., N.C. Sangster, J.W. Steel and G.H. Collins. 1993. Comparative pharmacokinetic disposition of closantel in sheep and goats. J. Vet. Pharmacol. Ther., 16: 254-260. Magzoub, m., O. H. Omer, E. M. Horoun, O. M. Mahmmed and Y. M. Abdel Hamid. 1997. Gastro-intestinal parasites of dromedary camels in gassim region, Saudi Arabia. Indian Vet. J. 74: 373-376. McEntee, K., M. Grauwels, C. Clercx, and M. Henroteaux. 1995. Closantel intoxication in dog. Vet. and Human Toxicology. 37: 234-236. Obwolo, M.J., G.O. Odiawo and J.S. Ogga. 1989. Toxicity of closantel-albendasole mixture in a flock of sheep and goats. Aust. Vet. J. 66: 228-229. Owen, I.L. 1988. Field trials with closantel and Haemonchus contortus in Papua New Guinea. Aust. Vet. J. 65: 267-270. Rolfe, P.F., J.C. Boray, C. Fitzgibbon, G. Parson, P. Kemsley and N. Sangster. 1990. Closantel resistance in Haemonchus contortus from sheep. Aust. Vet. J. 67: 29-31. Sanchez, N.I.C. and H. Quiroz-Romero. 1995. Evaluation of egg counts for Fasciola hepatica in sheep treated with closantel and nitroxinil. Veterinaria Mexico, 26: 151-154. Selim, M.K. and M.S. Rahman. 1972. Enteric nematodes of camels in Egypt. Egyptian Journal of Veterinary Science. 9: 75-80. Soliman, K.N. 1956. On a new species of the nematode genus Impalia from the camel in Egypt.British Veterinary Journal. 112, 507-512. Thienpont, D., F. Rochett, and O.F. Vanparijs. 1979. Diagnosing Helminthiasia by coprological examination. 2nd ed. Janssen Research Foundation, Belgium. Van Wyk, J.A. and F.S. Malan. 1988. Resistance of field strains of Haemonchus contortus to ivermectin, closantel, rafoxanide and the benzimidazole in South Africa. Veterinary Record. 123: 226-228. Van Wyk, J.A., H.M. Gerber and R.M. Alves. 1982. Slight resistance to the residual effect of closantel in a field strain of Haemonchus contortus which showed an increased resistance after one selection in the laboratory. Onderstpoort Journal of Veterinary Research. 49: 257-262. Yadav, C.L. and R. Kumar. 1994. Efficacy of rafoxanide and closantel against levamisol-resistant Haemonchus contortus of sheep. J. Vet. Parasitol. 8: 53-55.
MINAG-IICA BORRADOR DE TRABAJO1 INFORMACION BASE PARA LA ELABORACION DE UN PROGRAMA DE APOYO A LA AGROINDUSTRIA Y A LA AGROINDUSTRIA RURAL EN Pj. Zela S/n Jesús María Telf. 433 2899 SETIEMBRE DEL 2,005 1 Siendo este documento un Borrador de Trabajo, agradeceremos las colaboraciones encaminadas a